Molecular Templates (MTEM) Revenue & Revenue Breakdown
Molecular Templates Revenue Highlights
Latest Revenue (Y)
$57.31M
Latest Revenue (Q)
$572.00K
Main Segment (Y)
Research And Development Other
Main Geography (Y)
UNITED STATES
Molecular Templates Revenue by Period
Molecular Templates Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $57.31M | 190.10% |
2022-12-31 | $19.75M | -48.95% |
2021-12-31 | $38.70M | 147.50% |
2020-12-31 | $15.63M | -19.82% |
2019-12-31 | $19.50M | 167.73% |
2018-12-31 | $7.28M | 202.45% |
2017-12-31 | $2.41M | 100.00% |
2016-12-31 | - | -100.00% |
2015-12-31 | $76.92M | 422.45% |
2014-12-31 | $14.72M | 17.82% |
2013-12-31 | $12.49M | 112.97% |
2012-12-31 | $5.87M | 9362.90% |
2011-12-31 | $62.00K | 100.00% |
2010-12-31 | - | -100.00% |
2009-12-31 | $1.44M | - |
2008-12-31 | $1.44M | 0.28% |
2007-12-31 | $1.44M | -1.71% |
2006-12-31 | $1.46M | 111.74% |
2005-12-31 | $690.00K | 100.00% |
2004-12-31 | - | 100.00% |
2003-12-31 | - | 100.00% |
2002-12-31 | - | - |
Molecular Templates Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $572.00K | -94.84% |
2024-03-31 | $11.09M | 58.01% |
2023-12-31 | $7.02M | 3.24% |
2023-09-30 | $6.80M | 2.55% |
2023-06-30 | $6.63M | -80.29% |
2023-03-31 | $33.63M | 1187.90% |
2022-12-31 | $2.61M | -38.42% |
2022-09-30 | $4.24M | -4.01% |
2022-06-30 | $4.42M | -47.95% |
2022-03-31 | $8.49M | -52.76% |
2021-12-31 | $17.96M | 655.11% |
2021-09-30 | $2.38M | -84.28% |
2021-06-30 | $15.13M | 370.00% |
2021-03-31 | $3.22M | -7.92% |
2020-12-31 | $3.50M | -18.64% |
2020-09-30 | $4.30M | -28.84% |
2020-06-30 | $6.04M | 235.56% |
2020-03-31 | $1.80M | -61.60% |
2019-12-31 | $4.69M | 47.10% |
2019-09-30 | $3.19M | -38.84% |
2019-06-30 | $5.21M | -18.74% |
2019-03-31 | $6.41M | 57.30% |
2018-12-31 | $4.08M | 100.74% |
2018-09-30 | $2.03M | 115.15% |
2018-06-30 | $944.00K | 308.66% |
2018-03-31 | $231.00K | -71.83% |
2017-12-31 | $820.00K | 26.54% |
2017-09-30 | $648.00K | -78.40% |
2017-06-30 | $3.00M | 59.15% |
2017-03-31 | $1.89M | 432.49% |
2016-12-31 | $354.00K | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | -100.00% |
2015-12-31 | $65.87M | 1690.05% |
2015-09-30 | $3.68M | - |
2015-06-30 | $3.68M | -0.03% |
2015-03-31 | $3.68M | - |
2014-12-31 | $3.68M | 0.03% |
2014-09-30 | $3.68M | - |
2014-06-30 | $3.68M | -0.03% |
2014-03-31 | $3.68M | 14.60% |
2013-12-31 | $3.21M | 0.97% |
2013-09-30 | $3.18M | 0.03% |
2013-06-30 | $3.18M | 8.83% |
2013-03-31 | $2.92M | 44.58% |
2012-12-31 | $2.02M | 12.47% |
2012-09-30 | $1.80M | - |
2012-06-30 | $1.80M | 613.10% |
2012-03-31 | $252.00K | 306.45% |
2011-12-31 | $62.00K | 100.00% |
2011-09-30 | - | 100.00% |
2011-06-30 | - | 100.00% |
2011-03-31 | - | 100.00% |
2010-12-31 | - | 100.00% |
2010-09-30 | - | 100.00% |
2010-06-30 | - | 100.00% |
2010-03-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2009-09-30 | - | 100.00% |
2009-06-30 | - | 100.00% |
2009-03-31 | - | -100.00% |
2008-12-31 | $360.00K | -0.55% |
2008-09-30 | $362.00K | 0.84% |
2008-06-30 | $359.00K | - |
2008-03-31 | $359.00K | - |
2007-12-31 | $359.00K | - |
Molecular Templates Revenue Breakdown
Molecular Templates Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
---|---|---|---|---|---|
Research And Development Related Party | - | $13.14M | - | - | - |
Research And Development Other | $19.75M | $25.56M | - | - | - |
Grant | - | - | $3.21M | $2.77M | $6.00M |
Latest
Quarterly Revenue by Product
Product/Service | Jun 24 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Research And Development Revenue | $189.00K | $33.63M | $2.03M | - | - | - | - | - | - | - | - | - | - | - | - |
Grant Revenue | $383.00K | $238.00K | $3.00M | - | - | - | - | - | - | - | - | - | - | - | - |
Research And Development Other | - | - | - | $2.61M | $4.24M | $4.42M | $8.49M | - | - | - | - | - | - | - | - |
Research And Development Related Party | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Grant | - | - | - | - | - | - | - | $869.00K | $2.34M | $1.51M | $431.00K | $236.00K | $595.00K | $607.00K | $4.72M |
Latest
Molecular Templates Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
---|---|---|---|---|---|
UNITED STATES | $17.17M | $25.56M | $9.07M | - | $196.00K |
JAPAN | $2.59M | $13.14M | $6.57M | $19.50M | $7.09M |
Latest
Quarterly Revenue by Country
Country | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UNITED STATES | $6.63M | $33.63M | $2.61M | $4.24M | $4.42M | $5.90M | $17.96M | $2.23M | $2.98M | $1.89M | $2.73M | $2.98M | $1.47M | $-284.00K | $284.00K | - | - | $-1.00K | $117.00K | - |
JAPAN | - | - | - | - | - | $2.59M | - | $12.90M | $237.00K | $1.60M | $1.57M | $3.06M | $333.00K | $4.97M | $2.90M | $5.21M | $6.41M | $4.08M | $1.91M | - |
J P | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
U S | - | - | - | - | - | - | - | $2.38M | - | - | - | - | - | - | - | - | - | - | - | - |
Latest
Molecular Templates Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
CTMX | CytomX Therapeutics | $101.21M | $33.43M |
MTEM | Molecular Templates | $57.31M | $572.00K |
IKNA | Ikena Oncology | $9.16M | - |
ASMB | Assembly Biosciences | $7.16M | $6.84M |
KZR | Kezar Life Sciences | $7.00M | - |
IPSC | Century Therapeutics | $2.23M | $791.00K |
CBIO | Gyre Therapeutics | $794.00K | - |
VCNX | Vaccinex | $570.00K | $52.00K |
FBRX | Forte Biosciences | - | - |
TARA | Protara Therapeutics | - | - |
NGM | NGM Biopharmaceuticals | - | $165.00K |
NKTX | Nkarta | - | - |
TIL | Instil Bio | - | - |
ERAS | Erasca | - | - |
RNXT | RenovoRx | - | - |
NLTX | Neurogene | - | - |
TPST | Tempest Therapeutics | - | - |
MLYS | Mineralys Therapeutics | - | - |
MNPR | Monopar Therapeutics | - | - |
SRZN | Surrozen | - | - |
NUVB | Nuvation Bio | - | $727.00K |